GlassScriptPhysician profile
Satish Tadepalli
NPI 1972066652
$643.98
in general payments reported to CMS, 2019-2025
11 companies · $148 in 2025
The $148 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $13.93 · 2023: $301 · 2024: $181 · 2025: $148.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $630.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $630.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $286.30 | 2023-2024 | Closurefast, Venaseal |
| Scpharmaceuticals INC. | $124.63 | 2025 | |
| Lilly USA, LLC | $73.73 | 2023 | Mounjaro, Jardiance, Emgality |
| Novo Nordisk INC | $31.24 | 2023 | Ozempic, Rybelsus |
| Mannkind Corporation | $27.22 | 2023 | Afrezza |
| Cashflow Solutions, LLC | $23.81 | 2025 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
| Tactile Systems Technology INC | $23.17 | 2024 | Flexitouch Plus, Entre Plus |
| Astrazeneca Pharmaceuticals LP | $13.94 | 2023 | Breztri |
| Otsuka America Pharmaceutical, INC. | $13.93 | 2022 | |
| Exact Sciences Corporation | $13.14 | 2023 | Cologuard Collection Kit |
| Bausch Health US, LLC | $12.87 | 2023 | Aplenzin |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Satish Tadepalli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.